• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性-on-慢性肝衰竭对首次肝移植后90天死亡率的影响。 (注:这里“acute-on-chronic”不太常见,可根据具体医学语境准确理解其含义,比如可能是“急性加慢性”等意思,整体翻译尽量保留原文表述以符合专业文献翻译要求)

Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation.

作者信息

Levesque Eric, Winter Audrey, Noorah Zaid, Daurès Jean-Pierre, Landais Paul, Feray Cyrille, Azoulay Daniel

机构信息

Department of Anaesthesia and Surgical Intensive Care - Liver ICU, AP-HP Henri Mondor Hospital, Créteil, France.

INSERM, Unité U955, Créteil, France.

出版信息

Liver Int. 2017 May;37(5):684-693. doi: 10.1111/liv.13355. Epub 2017 Feb 27.

DOI:10.1111/liv.13355
PMID:28052486
Abstract

BACKGROUND

Acute-on-chronic liver failure (ACLF) is associated with a significant short-term mortality rate (23%-74%), depending on the number of organ failures. Some patients present with ACLF at the time of liver transplantation (LT). The aim of this study was to assess whether ACLF was also a prognostic factor after LT and, if applicable, to construct a score that could predict 90-day mortality.

METHODS

Three hundred and fifty cirrhotic patients, who underwent LT between January 2008 and December 2013, were enrolled. We used ACLF grades according to EASL-CLIF consortium criteria to categorize the cirrhotic patients. A propensity score was applied with an Inverse Probability Treatment Weighting in a Cox model. A predictive score of early mortality after LT was generated.

RESULTS

One hundred and forty patients (40%) met the criteria for ACLF. The overall mortality rate at 90 days post-transplant was 10.6% (37/350 patients). ACLF at the time of LT (HR: 5.78 [3.42-9.77], P<.001) was an independent predictor of 90-day mortality. Infection occurring during the month before LT, high recipient age and male recipient, the reason for LT and a female donor were also independent risk factors for early mortality. Using these factors, we have proposed a model to predict 90-day mortality after LT.

CONCLUSIONS

LT is feasible in cirrhotic patients with ACLF. However, we have shown that ACLF is a significant and independent predictor of 90-day mortality. We propose a score that can identify candidate cirrhotic patients in whom LT might be associated with futile LT.

摘要

背景

慢加急性肝衰竭(ACLF)与显著的短期死亡率(23%-74%)相关,具体取决于器官衰竭的数量。一些患者在肝移植(LT)时出现ACLF。本研究的目的是评估ACLF是否也是肝移植后的一个预后因素,如适用,构建一个能够预测90天死亡率的评分系统。

方法

纳入2008年1月至2013年12月期间接受肝移植的350例肝硬化患者。我们根据欧洲肝脏研究学会-慢性肝衰竭(EASL-CLIF)联盟标准使用ACLF分级对肝硬化患者进行分类。在Cox模型中应用倾向评分和逆概率处理加权。生成肝移植后早期死亡率的预测评分。

结果

140例患者(40%)符合ACLF标准。移植后90天的总死亡率为10.6%(37/350例患者)。肝移植时存在ACLF(HR:5.78[3.42-9.77],P<0.001)是90天死亡率的独立预测因素。肝移植前一个月内发生的感染、受体高龄和男性受体、肝移植原因以及女性供体也是早期死亡的独立危险因素。利用这些因素,我们提出了一个预测肝移植后90天死亡率的模型。

结论

对于合并ACLF的肝硬化患者,肝移植是可行的。然而,我们已经表明ACLF是90天死亡率的一个重要且独立的预测因素。我们提出了一个评分系统,该系统可以识别那些肝移植可能无效的肝硬化候选患者。

相似文献

1
Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation.急性-on-慢性肝衰竭对首次肝移植后90天死亡率的影响。 (注:这里“acute-on-chronic”不太常见,可根据具体医学语境准确理解其含义,比如可能是“急性加慢性”等意思,整体翻译尽量保留原文表述以符合专业文献翻译要求)
Liver Int. 2017 May;37(5):684-693. doi: 10.1111/liv.13355. Epub 2017 Feb 27.
2
Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.肝移植前慢加急性肝衰竭临床病程对移植后生存的影响。
J Hepatol. 2020 Mar;72(3):481-488. doi: 10.1016/j.jhep.2019.10.013. Epub 2019 Oct 25.
3
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.并发症是乙型肝炎病毒相关慢加急性肝衰竭患者死亡的主要危险因素:亚太地区的一项多国家研究。
Hepatol Int. 2019 Nov;13(6):695-705. doi: 10.1007/s12072-019-09992-x. Epub 2019 Oct 24.
4
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3.肝移植治疗失代偿期肝硬化患者:急性慢加急性肝衰竭 3 级的多中心研究
J Hepatol. 2017 Oct;67(4):708-715. doi: 10.1016/j.jhep.2017.06.009. Epub 2017 Jun 21.
5
Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.单中心验证 EASL-CLIF 联盟定义的慢加急性肝衰竭和 CLIF-SOFA 对肝硬化患者死亡率的预测价值。
Liver Int. 2015 May;35(5):1516-23. doi: 10.1111/liv.12597. Epub 2014 Jun 6.
6
Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival.肝移植前急性加重慢性肝功能衰竭患者的稳定化可预测移植后的生存率。
Aliment Pharmacol Ther. 2018 Jun;47(11):1502-1510. doi: 10.1111/apt.14627. Epub 2018 Apr 2.
7
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
8
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.预测因素和急性肝衰竭患者紧急肝移植的预后。
Dig Liver Dis. 2021 Aug;53(8):1004-1010. doi: 10.1016/j.dld.2021.03.030. Epub 2021 Apr 27.
9
Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.慢性肝衰竭急性发作综合征的临床病程及其对预后的影响。
Hepatology. 2015 Jul;62(1):243-52. doi: 10.1002/hep.27849. Epub 2015 May 29.
10
Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.细菌感染诱发的慢加急性肝衰竭与死亡率升高相关。
Liver Int. 2018 Apr;38(4):645-653. doi: 10.1111/liv.13568. Epub 2017 Sep 15.

引用本文的文献

1
Liver Transplantation in the Context of Acute-On-Chronic Liver Failure (ACLF): Where Do We Stand in 2025?急性慢性肝衰竭(ACLF)背景下的肝移植:2025年我们处于什么位置?
Transpl Int. 2025 Aug 5;38:14752. doi: 10.3389/ti.2025.14752. eCollection 2025.
2
Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study.一种预测慢性乙型肝炎急性肝衰竭移植后1年死亡率的新型预后模型的开发与验证:一项全国性、多中心队列研究。
EClinicalMedicine. 2025 Jul 17;86:103365. doi: 10.1016/j.eclinm.2025.103365. eCollection 2025 Aug.
3
Risk Evaluation and Recipient Selection in Adult Liver Transplantation: A Mixed-Methods Survey.
成人肝移植中的风险评估与受者选择:一项混合方法调查。
Can Liver J. 2024 Aug 28;7(3):352-367. doi: 10.3138/canlivj-2023-0037. eCollection 2024 Aug.
4
The role of recipient sex in the post-liver transplant prognosis of acute-on-chronic liver failure.受者性别在慢性肝衰竭急性发作肝移植后预后中的作用。
J Liver Transpl. 2025 May;18. doi: 10.1016/j.liver.2025.100267. Epub 2025 Mar 23.
5
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation.印度国家肝脏研究协会(INASL)关于判定肝移植无意义的指导声明。
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102539. doi: 10.1016/j.jceh.2025.102539. Epub 2025 Mar 28.
6
Liver transplantation improves prognosis across all grades of acute-on-chronic liver failure patients: A systematic review and meta-analysis.肝移植改善了所有等级的慢加急性肝衰竭患者的预后:一项系统评价和荟萃分析。
World J Gastroenterol. 2025 Mar 28;31(12):102007. doi: 10.3748/wjg.v31.i12.102007.
7
Reduced short-term survival following liver transplant in patients with acute-on-chronic liver failure: Reevaluating OPTN data.急性慢性肝衰竭患者肝移植后短期生存率降低:重新评估器官获取与移植网络(OPTN)数据。
Hepatol Commun. 2025 Feb 19;9(3). doi: 10.1097/HC9.0000000000000651. eCollection 2025 Mar 1.
8
Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver transplantation: a prospective observational study.重症监护病房中个体mHLA-DR轨迹作为肝移植后早期感染预测指标的前瞻性观察研究。
Crit Care. 2025 Feb 18;29(1):79. doi: 10.1186/s13054-025-05305-x.
9
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.慢加急性肝衰竭(ACLF):来自亚洲的“京都共识”步骤
Hepatol Int. 2025 Feb;19(1):1-69. doi: 10.1007/s12072-024-10773-4. Epub 2025 Feb 17.
10
Predicting futile outcomes following deceased donor liver transplantation in non-HCC patients with MELD-Na score above 30: a retrospective international multicenter cohort study.预测终末期肝病模型钠评分(MELD-Na)高于30分的非肝癌患者在接受脑死亡供体肝移植后的无效结局:一项回顾性国际多中心队列研究
Int J Surg. 2025 May 1;111(5):3148-3158. doi: 10.1097/JS9.0000000000002280.